Indica has traditionally been considered the better choice for pain, but the reality is more nuanced than picking one category over the other. Modern cannabis genetics have blurred the line between indica and sativa so thoroughly that nearly every strain available today is a hybrid. What actually determines how well a cannabis product relieves pain is its chemical profile: the specific combination of THC, CBD, and terpenes it contains, not the label on the jar.
Why the Indica vs. Sativa Distinction Falls Short
The cannabis industry is increasingly moving away from the indica/sativa framework and toward “chemovars,” or chemical varieties, because the old categories don’t reliably predict effects. Indica strains are traditionally associated with relaxation, pain reduction, and increased appetite, while sativas are linked to more energizing, cerebral effects. But decades of crossbreeding mean a strain labeled “sativa” might have a chemical profile nearly identical to one labeled “indica.”
As the New Mexico Department of Health puts it plainly: the old indica and sativa distinctions are not necessarily accurate, and many sativa varieties may be equally effective for chronic pain. Everything is a hybrid. Rather than shopping by category, you’ll get better results by looking at the cannabinoid and terpene content listed on the product label or provided by your dispensary.
What Actually Matters: THC, CBD, and Terpenes
Three chemical factors drive how well cannabis works for pain. THC is the primary pain-relieving compound, and higher-THC products tend to produce stronger analgesic effects. CBD doesn’t eliminate pain on its own as powerfully, but it modulates side effects like anxiety and may enhance THC’s benefits. Terpenes, the aromatic compounds that give each strain its smell and flavor, appear to play a larger role than most people realize.
Research from the University of Arizona Health Sciences found that cannabis terpenes, used by themselves, mimic the effects of cannabinoids and reduce pain sensation. When terpenes were combined with cannabinoids, the pain-relieving effects were amplified without increasing negative side effects. This synergy, often called the “entourage effect,” suggests that whole-plant products with rich terpene profiles may outperform products containing THC or CBD alone.
The terpenes most associated with pain relief include myrcene (earthy, musky), beta-caryophyllene (peppery, spicy), and linalool (floral, lavender-like). These show up in strains across the indica/sativa spectrum. A sativa-dominant strain rich in myrcene and caryophyllene could outperform an indica with a thin terpene profile. Exactly how terpenes interact with pain pathways, including whether they engage the body’s opioid system, is still being studied, but the early evidence is promising enough that researchers are exploring terpene-based strategies to lower the doses of other pain medications.
How Cannabis Compares to Other Pain Treatments
A 2025 study published in PAIN, the journal of the International Association for the Study of Pain, tracked 440 chronic pain patients certified for medical cannabis and compared them to over 8,000 patients treated with prescription pain medications in the same clinics. At three months, 38.6% of cannabis patients showed clinically meaningful improvements in pain, function, or overall status, compared to 34.9% of those on prescription medications. Statistical analysis found cannabis patients were 2.6 times more likely to respond favorably than the medication group.
For patients already on opioids, the results were striking. Those who added medical cannabis saw a mean 39.3% decrease in their opioid dosage over six months. This doesn’t mean cannabis replaces opioids for everyone, but it suggests a meaningful role in reducing reliance on them.
How to Choose a Strain for Pain
Instead of asking for the “best indica,” look for products with these characteristics:
- Moderate to high THC for direct pain relief, typically in the range that your tolerance allows without overwhelming side effects.
- Some CBD content to smooth out THC’s psychoactive edge. Balanced THC:CBD products work well for many pain patients, especially those new to cannabis.
- Terpene-rich profiles featuring myrcene, caryophyllene, or linalool. These are often listed on lab-tested product labels. If terpene data isn’t available, a strong, complex aroma is a rough indicator of terpene content.
For nerve-related pain specifically, both high-THC and high-CBD strains have shown benefit. The New Mexico Department of Health notes that high-CBD strains are also considered beneficial for chronic pain, not just the traditional high-THC indicas.
Starting Low and Building Up
If you’re new to using cannabis for pain, a widely recommended approach starts with CBD-only products at about 5 mg twice daily, gradually increasing by 10 mg every two to three days until reaching 40 mg per day. If CBD alone isn’t enough, THC is introduced at 2.5 mg per day and increased by 2.5 mg every few days. This step-up method minimizes side effects while helping you find the lowest effective dose.
People with lower tolerance, older adults, or those sensitive to medications can follow the same pattern but increase more slowly, adding just 1 mg of THC per week. Those with prior cannabis experience or severe pain may start with a balanced THC:CBD product at 2.5 to 5 mg of each, taken once or twice daily, and increase from there.
For sudden flares of pain, inhaled methods like vaporizing act faster than edibles or oils, typically within minutes rather than one to two hours. A balanced or THC-dominant vaporized product can serve as a rescue option while a longer-acting oral product handles baseline pain throughout the day.
The Bottom Line on Indica vs. Sativa
Indica-labeled products are a reasonable starting point for pain because they tend to have higher CBD, relaxing terpene profiles, and the kind of body-focused effects that complement pain management. But the label itself isn’t what’s doing the work. Two indicas can have wildly different chemical profiles, and a well-chosen sativa or hybrid can match or exceed what a poorly chosen indica delivers. Ask your dispensary about the THC and CBD percentages and the dominant terpenes. Those numbers will tell you far more about how the product will affect your pain than the word “indica” or “sativa” ever could.